{
    "title": "Moderna COVID vaccine sales forecasts fall short for 2022, 2023",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11385683/Moderna-shares-tumble-cutting-sales-forecast-COVID-vaccine.html",
    "date": "2022-11-03",
    "keywords": [
        "vaccine",
        "forecast",
        "company",
        "moderna",
        "covid19",
        "production",
        "year",
        "contract",
        "erman",
        "inc",
        "outlook",
        "street",
        "control",
        "manufacturing",
        "deal",
        "pfizer",
        "price",
        "market",
        "health",
        "catalent",
        "pfizerbiontech",
        "worth",
        "partner",
        "japan",
        "floor",
        "demand",
        "union",
        "alliance",
        "gavi",
        "organization",
        "booster",
        "shot",
        "government",
        "funding",
        "conference",
        "call",
        "thirdquarter",
        "customer",
        "base",
        "garay",
        "modernas",
        "officer",
        "predictability",
        "quarter",
        "roll",
        "bivalent",
        "coronavirus",
        "omicron",
        "executive",
        "stephane",
        "bancel",
        "lot",
        "quality",
        "manufacturer",
        "rollout",
        "regulator",
        "plant",
        "basis",
        "infancy",
        "analyst",
        "covid",
        "trading",
        "bengaluru",
        "michael",
        "maplewood",
        "jersey",
        "editing",
        "humer",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}